Medline, Inc. <MDLN.O>: Wells Fargo Cuts Target Price to $34 From $45
MDLN•Related News
Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNP
UPB•
Legend Biotech Q2 FY26 turns to net income of $33.2 million; revenue rises 51.9% to $387.5 million year over year
LEGN•
Harvard Apparatus adjusted EBITDA rises 11% year over year to $1.7 million; revenue increases 11% to $22.7 million in 2Q26
HRGN•
Hinge Health, Inc. <HNGE.N>: Truist Securities Raises Target Price to $112 From $85
HNGE•
Simon Property Group Inc <SPG.N>: Stifel raises target price to $209 from $194
SPG•